Ceftazidime-avibactam tolerance and persistence among difficult-to-treat KPC-producing Klebsiella pneumoniae clinical isolates from bloodstream infections
Artikel i vetenskaplig tidskrift, 2024

Purpose: Tolerance and persistence occur “silently” in bacteria categorized as susceptible by antimicrobial susceptibility testing in clinical microbiology laboratories. They are different from resistance phenomena, not well-studied, and often remain unnoticeable. We aimed to investigate and characterize ceftazidime-avibactam (CZA) tolerance/persistence in 80 Klebsiella pneumoniae isolates from bloodstream infections. Methods: We used the Tolerance Disk Test (TDtest) to detect CZA tolerance/persistence and investigate the avibactam (AVI) influence on them, and time-kill assays with minimal duration for killing (MDK) determination to characterize/differentiate CZA tolerance from persistence, for selected isolates. Whole genome sequencing was performed for 49/80 selected isolates to investigate genes related to beta-lactam tolerance/persistence and resistance as well as phylogeny studies. Results: Tolerance/persistence to CZA was detected in 48/80 (60%) isolates, all extensively drug-resistant (XDR) or multidrug-resistant, carbapenem-resistant K. pneumoniae (CRKp), KPC producers, and previously categorized as susceptible (not resistant) to CZA. No heteroresistance was detected. CZA tolerance/persistence occurred due to ceftazidime tolerance/persistence and was not related to AVI in the CZA combination. 5/11 isolates were characterized as CZA-tolerant and 5/11 as CZA-persistent. The single (1/11) XDR and CRKp non-KPC producer was truly susceptible. All the CZA-tolerant/persistent isolates (ST11, ST258, ST340, ST437, ST16, ST17, and ST307) harbored the carbapenemase-encoding gene blaKPC−2. Mutation in only two genes (rpoS and degQ) related to beta-lactam tolerance/persistence was found in only 7/49 CZA-tolerant/persistent isolates, suggesting the presence of yet unknown beta-lactam tolerance/persistence genes. Conclusion: Among the K. pneumoniae bloodstream isolates studied, 60%, previously categorized as susceptible to CZA, were, actually, tolerant/persistent to this antibiotic, all these KPC producers.

Tolerance disk test (TDtest)

Antibiotic resistant bacteria

Minimal duration for killing (MDK)

Time-kill assays

Författare

N. Abichabki

Universidade de Sao Paulo (USP)

G. G. Gaspar

Universidade de Sao Paulo (USP)

L. R. Bortolato

Universidade de Sao Paulo (USP)

D. A.F.S. Lima

Universidade de Sao Paulo (USP)

L. N. Silva

Universidade de Sao Paulo (USP)

R. H.C. Pocente

Universidade de Sao Paulo (USP)

J. C. Ferreira

Universidade de Sao Paulo (USP)

T. C. Ogasawara

Universidade de Sao Paulo (USP)

D. Pereira

Universidade Federal do Rio Grande do Sul (UFRGS)

R. R. Guerra

Universidade Federal do Rio Grande do Sul (UFRGS)

C. Wilhelm

Universidade Federal do Rio Grande do Sul (UFRGS)

P. Barth

Universidade Federal do Rio Grande do Sul (UFRGS)

A. F. Martins

Universidade Federal do Rio Grande do Sul (UFRGS)

A. Barth

Universidade Federal do Rio Grande do Sul (UFRGS)

Gilberto U.L. Braga

Universidade de Sao Paulo (USP)

E. C.P. De Martinis

Universidade de Sao Paulo (USP)

Johan Bengtsson Palme

Chalmers, Life sciences, Systembiologi

Göteborgs universitet

CARe

F. Bellissimo-Rodrigues

Universidade de Sao Paulo (USP)

V. R. Bollela

Universidade de Sao Paulo (USP)

A. L.C. Darini

Universidade de Sao Paulo (USP)

L. N. Andrade

Universidade de Sao Paulo (USP)

European Journal of Clinical Microbiology and Infectious Diseases

0934-9723 (ISSN) 1435-4373 (eISSN)

Vol. In Press

Framtidens patogener och resistensgener

Stiftelsen för Strategisk forskning (SSF) (FFL21-0174), 2022-08-01 -- 2027-12-31.

Ämneskategorier

Infektionsmedicin

Biologiska vetenskaper

DOI

10.1007/s10096-024-05005-4

PubMed

39614972

Mer information

Senast uppdaterat

2024-12-12